Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Jun 16, 2023; 15(6): 469-479
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.469
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.469
Characteristic | Value |
Age (yr) | 42.9 ± 9.4 |
% Female | 78.5 |
Weight (kg) | 127.3 ± 20.1 |
BMI (kg/m2) | 44.8 ± 4.7 |
Comorbidities, n (%) | |
Hypertension | 143 (35.4%) |
Type II diabetes | 72 (17.8%) |
Hyperlipidemia | 68 (16.8%) |
3 mo | 6 mo | 12 mo | 15 mo | 24 mo | 36 mo | |
Total cohort | 404 | 404 | 404 | 404 | 404 | 404 |
Not yet out of window | 52 | 122 | 217 | 266 | 309 | 387 |
Expected1 | 352 | 282 | 187 | 138 | 95 | 17 |
Actual | 312 | 233 | 151 | 112 | 82 | 15 |
% Follow-up | 88.60% | 82.60% | 80.70% | 81.20% | 86.30% | 88.30% |
- Citation: Maselli DB, Hoff AC, Kucera A, Weaver E, Sebring L, Gooch L, Walton K, Lee D, Cratty T, Beal S, Nanduri S, Rease K, Gainey CS, Eaton L, Coan B, McGowan CE. Endoscopic sleeve gastroplasty in class III obesity: Efficacy, safety, and durability outcomes in 404 consecutive patients. World J Gastrointest Endosc 2023; 15(6): 469-479
- URL: https://www.wjgnet.com/1948-5190/full/v15/i6/469.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i6.469